Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115253) titled 'To evaluate the safety and efficacy of HL-1186 tablets for abdominal postoperative analgesia in a multicenter, randomized, double-blind, placebo-controlled phase IIa clinical trial' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Xiangya Hospital of Central South University
Condition:
Pain
Intervention:
Group HL-1186:Oral HL-1186
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-12-25
Target Sample Size: Group HL-1186:20;Placebo group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...